{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:30:26Z","timestamp":1775017826277,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016308","name":"Bpifrance","doi-asserted-by":"publisher","award":["I1301001W"],"award-info":[{"award-number":["I1301001W"]}],"id":[{"id":"10.13039\/100016308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-CE20-0025"],"award-info":[{"award-number":["ANR-18-CE20-0025"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bmc.2023.117453","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:30:15Z","timestamp":1693225815000},"page":"117453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design of a structure-activity relationship model of vitamin K epoxide reductase (VKORC1) inhibitors combining chemical synthesis of new compounds, enzymatic assays and molecular modelling"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7973-4896","authenticated-orcid":false,"given":"Nolan","family":"Chatron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Boulven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Montagut-Romans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8792-1739","authenticated-orcid":false,"given":"Flavien","family":"Ponsot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00efwenn","family":"Jacolot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7759-8424","authenticated-orcid":false,"given":"Herv\u00e9","family":"Caruel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Beno\u00eet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-295X","authenticated-orcid":false,"given":"Florence","family":"Popowycz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Lattard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117453_b0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2165\/00003088-200544120-00003","article-title":"Comparative Pharmacokinetics of Vitamin K Antagonists: Warfarin, Phenprocoumon and Acenocoumarol","volume":"44","author":"Ufer","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bmc.2023.117453_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2156-10-4","article-title":"Novel Mutations in the VKORC1 Gene of Wild Rats and Mice \u2013 a Response to 50 Years of Selection Pressure by Warfarin?","volume":"10","author":"Rost","year":"2009","journal-title":"BMC Genet"},{"key":"10.1016\/j.bmc.2023.117453_b0015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature02214","article-title":"Mutations in VKORC1 Cause Warfarin Resistance and Multiple Coagulation Factor Deficiency Type 2","volume":"427","author":"Rost","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117453_b0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature02254","article-title":"Identification of the Gene for Vitamin K Epoxide Reductase","volume":"427","author":"Li","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117453_b0025","first-page":"103","article-title":"Structure and Function of Vitamin K Epoxide Reductase","volume":"Vol. 78","author":"Tie","year":"2008"},{"key":"10.1016\/j.bmc.2023.117453_b0030","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1021\/bi700527j","article-title":"The Conversion of Vitamin K Epoxide to Vitamin K Quinone and Vitamin K Quinone to Vitamin K Hydroquinone Uses the Same Active Site Cysteines","volume":"46","author":"Jin","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117453_b0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.bi.54.070185.002331","article-title":"VITAMIN K-DEPENDENT CARBOXYLASE","volume":"54","author":"Suttie","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bmc.2023.117453_b0040","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1017\/S0007114509382100","article-title":"The Effect of Menaquinone-7 (Vitamin K2) Supplementation on Osteocalcin Carboxylation in Healthy Prepubertal Children","volume":"102","author":"van Summeren","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1016\/j.bmc.2023.117453_b0045","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/mnfr.201300743","article-title":"The Realm of Vitamin K Dependent Proteins: Shifting from Coagulation toward Calcification","volume":"58","author":"Willems","year":"2014","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.bmc.2023.117453_b0050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1042\/bj0291273","article-title":"The Antihaemorrhagic Vitamin of the Chick","volume":"29","author":"Dam","year":"1935","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2023.117453_b0055","first-page":"35","article-title":"The Vitamin K Cycle","volume":"Vol. 78","author":"Oldenburg","year":"2008"},{"key":"10.1016\/j.bmc.2023.117453_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2007.02549.x","article-title":"VKORC1: Molecular Target of Coumarins","volume":"5","author":"Oldenburg","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bmc.2023.117453_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2020.616276","article-title":"Biomarkers Potency to Monitor Non-Target Fauna Poisoning by Anticoagulant Rodenticides","volume":"7","author":"Rached","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.bmc.2023.117453_b0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/FPC.0000000000000143","article-title":"Variation in Genes Controlling Warfarin Disposition and Response in American Indian and Alaska Native People: CYP2C9, VKORC1, CYP4F2, CYP4F11","volume":"25","author":"Fohner","year":"2015","journal-title":"GGCX. Pharmacogenet. Genomics"},{"key":"10.1016\/j.bmc.2023.117453_b0075","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/jth.12019","article-title":"VKORC1 Mutations Detected in Patients Resistant to Vitamin K Antagonists Are Not All Associated with a Resistant VKOR Activity","volume":"10","author":"Hodroge","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bmc.2023.117453_b0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00000441-199402000-00011","article-title":"Long-Term Oral Anticoagulant Therapy: Update on Indications, Therapeutic Ranges, and Monitoring","volume":"307","author":"Raj","year":"1994","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bmc.2023.117453_b0085","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/ece3.2829","article-title":"Adaptative Evolution of the Vkorc1 Gene in Mus Musculus Domesticus Is Influenced by the Selective Pressure of Anticoagulant Rodenticides","volume":"7","author":"Goulois","year":"2017","journal-title":"Ecol Evol"},{"key":"10.1016\/j.bmc.2023.117453_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1538-7836.2010.04095.x","article-title":"Thirteen Novel VKORC1 Mutations Associated with Oral Anticoagulant Resistance: Insights into Improved Patient Diagnosis and Treatment","volume":"9","author":"Watzka","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bmc.2023.117453_b0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.fob.2013.02.001","article-title":"New Insights into the Catalytic Mechanism of Vitamin K Epoxide Reductase (VKORC1) - The Catalytic Properties of the Major Mutations of RVKORC1 Explain the Biological Cost Associated to Mutations","volume":"3","author":"Matagrin","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bmc.2023.117453_b0100","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/bi00293a031","article-title":"Warfarin Inhibition of Vitamin K 2,3-Epoxide Reductase in Rat Liver Microsomes","volume":"22","author":"Fasco","year":"1983","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117453_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/bj2410389","article-title":"Design of a System in Vitro That Mimics the Situation in Vivo","volume":"241","author":"Wallin","year":"1987","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2023.117453_b0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ps.2780430112","article-title":"Warfarin-Based Rodenticides: Mode of Action and Mechanism of Resistance","volume":"43","author":"Thijssen","year":"1995","journal-title":"Pestic Sci"},{"key":"10.1016\/j.bmc.2023.117453_b0115","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bmc.2007.01.014","article-title":"Synthesis and Structure-Activity Relationships of Novel Warfarin Derivatives","volume":"15","author":"Gebauer","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117453_b0120","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.bmcl.2017.02.017","article-title":"Synthesis and Biological Evaluation of C-3 Aliphatic Coumarins as Vitamin K Antagonists","volume":"27","author":"Montagut-Romans","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117453_b0125","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s12010-009-8619-7","article-title":"Synthesis and Insecticidal Activity of New 4-Hydroxy-2H-1-Benzopyran-2-One Derivatives","volume":"159","author":"Wang","year":"2009","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.bmc.2023.117453_b0130","article-title":"Computational Ligands to VKORC1s and CYPs. Could They Predict New Anticoagulant Rodenticides?; preprint","author":"Bermejo-Nogales","year":"2021","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.bmc.2023.117453_b0135","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.bmc.2010.04.009","article-title":"Synthesis, Anticoagulant and PIVKA-II Induced by New 4-Hydroxycoumarin Derivatives","volume":"18","author":"Abdelhafez","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117453_b0140","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.bmcl.2019.05.039","article-title":"Determining the Necessity of Phenyl Ring \u03c0-Character in Warfarin","volume":"29","author":"Xing","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117453_b0145","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/jth.15209","article-title":"A Novel Vitamin K Derived Anticoagulant Tolerant to Genetic Variations of Vitamin K Epoxide Reductase","volume":"19","author":"Chen","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bmc.2023.117453_b0150","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.bmcl.2005.03.005","article-title":"Design and Synthesis of Novel Diphenacoum-Derived, Conformation-Restricted Vitamin K 2,3-Epoxide Reductase Inhibitors","volume":"15","author":"Chen","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117453_b0155","doi-asserted-by":"crossref","first-page":"eabc5667","DOI":"10.1126\/science.abc5667","article-title":"Structural Basis of Antagonizing the Vitamin K Catalytic Cycle for Anticoagulation","volume":"371","author":"Liu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117453_b0160","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1111\/febs.16386","article-title":"Structural Features Determining the Vitamin K Epoxide Reduction Activity in the VKOR Family of Membrane Oxidoreductases","volume":"289","author":"Shen","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.bmc.2023.117453_b0165","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117453_b0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An Open Chemical Toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Cheminformatics"},{"key":"10.1016\/j.bmc.2023.117453_b0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117453_b0180","unstructured":"The PyMOL Molecular Graphics System, Version 1.8. Schr\u00f6dinger, LLC: New York, NY, USA 2015."},{"key":"10.1016\/j.bmc.2023.117453_b0185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative Protein Modelling by Satisfaction of Spatial Restraints","volume":"234","author":"\u0160ali","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2023.117453_b0190","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2023.117453_b0195","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/acs.biochem.9b01084","article-title":"Structural Investigation of the Vitamin K Epoxide Reductase (VKORC1) Binding Site with Vitamin K","volume":"59","author":"Chatron","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117453_b0200","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: Fast, Flexible, and Free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2023.117453_b0205","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone \u03d5, \u03c8 and Side-Chain \u03c7 1 and \u03c7 2 Dihedral Angles","volume":"8","author":"Best","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2023.117453_b0210","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2023.117453_b0215","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jp212503e","article-title":"Derivation and Systematic Validation of a Refined All-Atom Force Field for Phosphatidylcholine Lipids","volume":"116","author":"J\u00e4mbeck","year":"2012","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.bmc.2023.117453_b0220","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1182\/blood-2018-05-846592","article-title":"Evaluation of Oral Anticoagulants with Vitamin K Epoxide Reductase in Its Native Milieu","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2023.117453_b0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nsmb.3338","article-title":"Warfarin and Vitamin K Compete for Binding to Phe55 in Human VKOR","volume":"24","author":"Czogalla","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmc.2023.117453_b0230","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1182\/blood-2013-05-501692","article-title":"Human VKORC1 Mutations Cause Variable Degrees of 4-Hydroxycoumarin Resistance and Affect Putative Warfarin Binding Interfaces","volume":"122","author":"Czogalla","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2023.117453_b0235","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1139\/bcb-2021-0441","article-title":"Overexpression of Protein Disulfide Isomerase Enhances Vitamin K Epoxide Reductase Activity","volume":"100","author":"Chetot","year":"2022","journal-title":"Biochem. Cell Biol. Biochim. Biol. Cell."},{"key":"10.1016\/j.bmc.2023.117453_b0240","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/acs.biochem.5b00716","article-title":"Membrane Composition Influences the Activity of in Vitro Refolded Human Vitamin K Epoxide Reductase","volume":"54","author":"Jaenecke","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117453_b0245","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/jp400264x","article-title":"How Warfarin\u2019s Structural Diversity Influences Its Phospholipid Bilayer Membrane Permeation","volume":"117","author":"Karlsson","year":"2013","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.bmc.2023.117453_b0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nsmb.3333","article-title":"Warfarin Traps Human Vitamin K Epoxide Reductase in an Intermediate State during Electron Transfer","volume":"24","author":"Shen","year":"2017","journal-title":"Nat Struct Mol Biol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:23:12Z","timestamp":1760836992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"alternative-id":["S0968089623003012"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117453","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of a structure-activity relationship model of vitamin K epoxide reductase (VKORC1) inhibitors combining chemical synthesis of new compounds, enzymatic assays and molecular modelling","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117453"}}